Alpha-2 agonists in the threatment of attention deficit hyperactivity disorder

Journal of Child and Adolescent Psychiatric Nursing, Oct-Dec 1999 by Scahill, Lawrence, Barloon, Linda, Farkas, Lesley

Acknowledgments. This work was funded in part by the following USPHS grants: MH-70009, MH-30929, MH-49351, HD-- 03008, RR-06022, and by a grant from the Tourette Syndrome Association. The authors are grateful to Dr. Amy Arnsten for providing the figure used in this paper.

Key words: ADHD, alpha-2 agonists, clonidine, guanfacine, tics

References

Arnsten, A.El, Steere, J.C., & Hunt, R.D. (1996). The contribution of alpha-2 noradrenergic mechanisms to prefrontal cortical cognitive functions: Potential significance to attention-deficit hyperactivity disorder. Archives of General Psychiatry, 53,448-455.

Balldin, J., Berggren, U., Eriksson, E., Lindstedt, G., & Sundkler, A. (1993). Guanfacine as an alpha-2-agonist inducer of growth hormone secretion. A comparison with clonidine. Psychoneuroendocrinology, 18(l),45-55.

Barkley, R.A., McMurray, M.B., Edelbrock, C.S., & Robbins, K. (1992). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systen-dc, placebo-controlled evaluation. Pediatrics, 86,184-192.

Barrickman, L.L., Perry, P.J., Allen, Aj., Kuperman, S., Arndt, S.V., Herrmann, K.J., & Schumacher, E. (1995). Bupropion versus methviphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34,649-657_.__

Biederman, J., Baldessarini, R.J., Wright, V., Knee, D., & Harmatz, J.S. (1989). A double-blind placebo controlled study of desipramine in the treatment of ADD: 1. Efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 28,777-784.

Borcherding, B.G., Keyser, C.S., Rappoport, J.L., Elia, J., & Amass, J. (1990). Motor/visual tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Research, 33, 83 - 94.

Buitelaar, J. K., Van der Gaag, R.J., Swaab-Barneveld, H., & Kuiper, M. (1996). Pindolol and methlyphenidate in children with attentiondeficit hyperactivity disorder. Clinical efficacy and side-effects. Journal of Child Psychology and Psychiatry, 37,587-595.

Castellanos, FX, Giedd, J.N., Elia, J., Marsh, W., Ritchie, G.F. Hamburger, S.D., & Rappoport, J.L. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 589 - 596.

Chappell, P.B., Riddle, M.A., Scahill, L., Lynch, K.A., Schultz, R., Arnsten, A., Leckman, I.F., & Cohen, D.J. (1995). Guanfacine treatment of comorbid attention deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 34,1140-1146.

Conner, D.F (1993). Beta blockers for aggression: A review of the pediatric experience. Journal of Child and Adolescent Psychopharmacology, 3,99-114. Conners, CK, Casat, C.D, Gualtieri, C.T., Weller, E., Reader, M., Reiss, A.,

Weller, R.A., Khayrallah, M., & Ascher, J. (1996). Bupropion hydrochloride in attention deficit disorder with hyperactivity. Journal of the American Academy of Child and Adolescent Psychiatry, 34,1314-1321.